Rheumnow Podcast

934 Folgen

1. We've Got to Talk about CAR T cells

   Vom: 14.6.2024
2. EULAR 2024 Daily Podcasts Day1&2

   Vom: 13.6.2024
3. Predicting Palindromic Prognosis

   Vom: 13.6.2024
4. A Step Closer to Identifying Phenotypes of RA ILD

   Vom: 13.6.2024
5. Top 3 Messages About JAK Inhibitor Safety

   Vom: 13.6.2024
6. Pain in RA: Different Drugs for Different Mechanisms

   Vom: 13.6.2024
7. Giant Cell Arteritis and Polymyalgia Rheumatica Update

   Vom: 13.6.2024
8. JAK Inhibitors for New Indications

   Vom: 13.6.2024
9. Top 3 Messages About JAK Inhibitor Safety

   Vom: 13.6.2024
10. Pain in RA: Different Drugs for Different Mechanisms

    Vom: 13.6.2024
11. JAK Inhibitors for New Indications

    Vom: 13.6.2024
12. Potential of Radiomics to Predict TNF Therapy Outcomes in axSpA

    Vom: 13.6.2024
13. Treat to Target Outcomes in Early AxSpA

    Vom: 13.6.2024
14. Does Telemonitoring in SpA Work?

    Vom: 13.6.2024
15. PsA Treatment: is Earlier Better?

    Vom: 13.6.2024
16. JAK Inhibitors for New Indications

    Vom: 13.6.2024
17. Transition from Psoriasis to PsA: Can we Prevent It?

    Vom: 13.6.2024
18. EULAR 2024 Daily Recap - Days 1 & 2

    Vom: 13.6.2024
19. Mechanistic Promise in RA Doesn’t Always Mean Actual Gain

    Vom: 13.6.2024
20. The Role of Psychosocial Determinants in the Management of Rheumatoid Arthritis

    Vom: 13.6.2024